Screener
Biodesix, Inc. BDSX Income Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $26.86M+34.2% | $25.56M+42.3% | $28.76M+40.8% | $21.77M+19.9% | $20.02M+11.7% | ||
| $3.14M-4.1% | $3.29M+14.5% | $2.87M+18.9% | $2.99M+17.5% | $3.27M+27.8% | ||
| $24.28M+8.3% | $24.26M+18.6% | $22.97M+13.6% | $21.71M+8.5% | $22.41M+14.0% | ||
| $32.25M+8.4% | $31.76M+17.2% | $30.72M+13.5% | $28.82M+7.8% | $29.74M+13.7% | ||
| -$5.39M+44.6% | -$6.2M+32.1% | -$1.97M+70.4% | -$7.05M+17.9% | -$9.72M-18.0% | ||
| -20.1%+28.5pp | -24.3%+26.6pp | -6.8%+25.7pp | -32.4%+14.9pp | -48.6%-2.6pp | ||
| $1.98M+4.4% | $1.98M+17.3% | $2.06M+17.5% | $2.07M+1.6% | $1.9M-2.0% | ||
| -$1.89M-7.8% | -$1.59M+19.0% | -$2.01M-25.7% | -$1.67M+0.1% | -$1.75M+32.0% | ||
| -$7.27M+36.6% | -$7.79M+29.8% | -$3.98M+51.8% | -$8.72M+15.0% | -$11.47M-6.1% | ||
| -27.1%+30.2pp | -30.5%+31.3pp | -13.8%+26.5pp | -40%+16.5pp | -57.3%+3.0pp | ||
| -$0.71+54.5% | -$0.81+46.7% | -$0.43+58.3% | -$1.16+17.1% | -$1.56-1,850% | ||
| -$4M+51.7% | -$4.81M+37.6% | -$580K+88.8% | -$5.65M+20.5% | -$8.28M-21.3% | ||
| -14.9%+26.5pp | -18.8%+24.1pp | -2%+23.4pp | -25.9%+13.2pp | -41.4%-3.3pp | ||
| -$5.39M+44.6% | -$6.2M+32.1% | -$1.97M+70.4% | -$7.05M+17.9% | -$9.72M-18.0% |
FAQ
- What is Biodesix, Inc.'s revenue?
- Biodesix, Inc. (BDSX) generated $102.9M in revenue over the trailing twelve months, up 34.5% year over year.
- Is Biodesix, Inc. profitable?
- Biodesix, Inc. is not currently profitable: it reported a net loss of $27.8M over the trailing twelve months, a -27.0% net margin.
- What is Biodesix, Inc.'s earnings per share?
- Biodesix, Inc.'s diluted EPS over the trailing twelve months is $-3.11.
- Where does Biodesix, Inc.'s income statement data come from?
- Every line is extracted from Biodesix, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
